Projects per year
Abstract
CSPG4/NG2 is a multifunctional transmembrane protein with limited distribution in adult tissues including articular cartilage. The purpose of the current study was to investigate possible roles for CSPG4/NG2 in chondrosarcomas and to establish whether this molecule may have potential for targeted therapy. Stable knock down of CSPG4/NG2 in the JJ012 chondrosarcoma cell line by shRNA resulted in decreased cell proliferation and migration as well as a decrease in gene expression of the MMP (matrix metalloproteinase) 3 protease and ADAMTS-4 aggrecanase. Chondrosarcoma cells in which CSPG4/NG2 was knocked down were more sensitive to doxorubicin than wild type cells. The results indicate that CSPG4/NG2 has roles in regulating chondrosarcoma cell function in relation to growth, spread and resistance to chemotherapy and that anti-CSPG4/NG2 therapies may have potential in the treatment of surgically irresectable chondrosarcoma.
Original language | English |
---|---|
Pages (from-to) | 178-86 |
Number of pages | 9 |
Journal | International Journal of Experimental Pathology |
Volume | 97 |
Issue number | 2 |
Early online date | 12 Jun 2016 |
DOIs | |
Publication status | E-pub ahead of print - 12 Jun 2016 |
Fingerprint
Dive into the research topics of 'Functional Roles for CSPG4/NG2 in Chondrosarcoma'. Together they form a unique fingerprint.Projects
- 1 Finished
-
NG2/CSPG4 in Osteosarcoma : functional roles and novel therapeutic target
Salter, D.
1/10/14 → 30/09/17
Project: Research